Skip to main content
Download PDF
  • Sexologie
  • Published:

Effet iatrogène des médicaments à visée cardiovasculaire sur la fonction sexuelle érectile de l'homme

Effets of long lasting treatments with cardiovascular drugs on erectile function

Andrologie volume 8, pages 391–404 (1998)Cite this article

Resumé

Les maladies cardiovasculaires (C.V.) sont fréquemment des états pathologiques chroniques qui vont nécessiter un traitement de longue durée.

Cette thérapeutique prolongée s'applique parfois à des sujets asymptomatiques comme le sont de nombreux hypertendus légers à modérés.

Dans ces situations, le respect de la qualité de vie, de la sexualité en particulier, est une condition essentielle à l'observance du traitement.

Les médicaments à visée C. V. ont communément une mauvaise réputation vis à vis de la fonction érectile.

Nous verrons que cette opinion doit être nuancée à la lumière des données de la littérature.

Nous envisagerons également l'attitude pratique, face à un patient donné présentant des troubles de l'érection, que ce soit lors du bilan initial pré-thérapeutique ou en cours de traitement à visée cardiovasculaire.

Abstract

Cardiovascular diseases are pathological chronicle states needing long lasting treatment. Cardiovascular drugs commonly have bad reputation for their side effects on erectile function.

However, following the data of the literature, this responsibility is not so cleaaly assessed and often controversial.

We should remenber that:

  • - Sexual status should be known before cardiovascular drug prescription.

  • - In case of sexual side effects, chronological data may be helpfull to assess the responsibility of the drug.

  • - Remind that erectile dysfunction is not always a side effect of this treatment.

  • - Dose range and number of molecules should be as low as possible

References

  1. ABRAMOWICZ M (ed): Drugs that cause sexual dysfunction. Med Lett 1987, 29, 65.

  2. BAUER GE, BAKER J, HUNYOR SN, MARSHALL P. Side-effects of antihypertensive treatment: a placebo-controlled study. Clin Sci Mol Med 1978, 55, 341s-344s.

    Google Scholar 

  3. BAUER GE, HUNYOR SN, BAKER J, MARSHALL P. Clinical side effects during antihypertensive therapy: a placebo-controlled double-blind study. Postgrad Med Commun (Special report) 1981, 49–54.

  4. BETO JA, BANSAL VK. Quality of life in Treatment of Hypertension, A Metaanalysis of Clinical Trials. Am J Hypertens 1992, 5, 125–133.

    PubMed  CAS  Google Scholar 

  5. β-Blocker Heart Attack Trial Research Group. A randomised trial of propranolol in patients with acute myocardial infarction. JAMA 1982, 247(12), 1707–1714.

    Article  Google Scholar 

  6. BROCK GB, LUE TF. Drug-Induced Male Sexual Dysfunction, An Update. Drug Safety 1993, 8(6), 414–426.

    Article  PubMed  CAS  Google Scholar 

  7. BROEKMAN M, HAENSEL S, VAN DE VEN L, SLOB K. Bisoprolol and Hypertension: Effects on Sexual Functioning in Men. J Sex Marit Ther 1992, 18(4), 325–331.

    CAS  Google Scholar 

  8. BROWN JJ, CHINN RH, DÜSTERDIECK GO. Hypertension and hyperaldosteronism with low plasma renin concentration. Proc R Soc Med 1969, 62, 1258–60.

    PubMed  CAS  Google Scholar 

  9. BURKE JR, HIRST G. Priapism and prazosin. Med J Aust 1980, 1, 382.

    PubMed  CAS  Google Scholar 

  10. CHANG SW, FINE R, SIEGEL D, CHESNEY M, BLACK D, HULLEY SB. The Impact of Diuretic Therapy on Reported Sexual Function. Arch Intern Med 1991, 151, 2402–2408.

    Article  PubMed  CAS  Google Scholar 

  11. Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA 1975, 231, 360.

    Article  Google Scholar 

  12. DOLLERY CT, HARRINGTON M. Methyldopa in hypertension. Lancet 1962, 1, 759.

    Article  PubMed  CAS  Google Scholar 

  13. GUPTA S, DALEY J, PABBY A, HAMAWAY K, GHOLAMI S et al. A new mechanism for digoxin-associated impotence: in vitro and in vivo study. Proceed Am Urol Assoc 1996, 155, 621 A.

    Google Scholar 

  14. ITSKOVITZ HD. Alpha 1-Blockade for the Treatment of Hypertension: A Megastudy of Terazosin in 2214 Clinical Practice Settings. Clinical Therapeutics 1994, 16 (3), 490–504.

    PubMed  CAS  Google Scholar 

  15. JEUNEMAITRE X, CHATELLIER G, KREFT-JAIS C, CHARRU A, DEVRIES C et al. Efficacy and tolerance of Spironolactone in essential hypertension. Am J Cardiol 1987, 60, 820–825.

    Article  PubMed  CAS  Google Scholar 

  16. JULIAN DG, JACKSON FS, PRESCOTT RJ, SZEKELY P. Controlled trial of sotalol for one year after myocardial infarction. Lancet 1982, May 22, 1142–1147.

    Google Scholar 

  17. KHAN A, CAMEL G, PERRY M. Clonidine: a new antihypertensive agent. Curr Ther Res 1970, 12, 10.

    PubMed  CAS  Google Scholar 

  18. KOLODNY RC. Effects of alpha-methyldopa on male sexual function. Sexuality and Disability 1987, 1, 223–227.

    Article  Google Scholar 

  19. MATERSON BJ, REDA DJ, CUSHMAN WC, MASSIE BM, FREIS ED et al. Single-drug therapy for hypertension in men. N Engl J Med 1993, 328, 914–21.

    Article  PubMed  CAS  Google Scholar 

  20. MEINHARDT W, KROPMAN RF, VERMEIJ P, LYCKLAMA AAB, ZWARTENDIJK J. The influence of medication on erectile function. Intern J Impotence Res 1997, 9, 17–26.

    Article  CAS  Google Scholar 

  21. MESTON CM, GORZALKA BB. Psychoactive drugs and human sexual behavior: the role of seroti-nergic activity. J Psychoactive Drugs 1992, 24 (1), 1–40.

    PubMed  CAS  Google Scholar 

  22. MROCZEK WJ, DAVIDOV M, FINNERTY FA. Prolonged treatment with clonidine. Am J Cardiol 1972, 30, 536–41.

    Article  PubMed  CAS  Google Scholar 

  23. NORWEGIAN MULTICENTER Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981, 304(14), 801–7.

    Article  Google Scholar 

  24. ONESTI G, BOCK KD, HEIMSOTH V et al. Clonidine: a new antihypertensive agent. Am J Cardiol 1971, 28, 74–83.

    Article  PubMed  CAS  Google Scholar 

  25. OSBORNE DR. Propranolol and Peyronie's disease. Lancet 1977, 1, 111.

    Google Scholar 

  26. PAPADOPOULOS C. Cardiovascular Drugs and Sexuality, A Cardiologist's Review. Arch Intern Med 1980, 140, 1341–1345.

    Article  PubMed  CAS  Google Scholar 

  27. PILLAY VKG. Some side-effects of alpha-methyldopa. S Afr Med J 1976, 50, 625.

    PubMed  CAS  Google Scholar 

  28. PITTS NE. The clinical evaluation of prazosin. In: Cottone DWK, ed. Prazosin: evaluation of a new antihypertensive agent. Amsterdam. Excerpta Medica 1974, 149–63.

    Google Scholar 

  29. ROSEN RC, KOSTIS JB, JEKELIS AW. Beta-blocker effects on sexual function in normal males. Archiv Sex Behav 1988, 17, 241–255.

    Article  CAS  Google Scholar 

  30. SMITH PJ, TALBERT RL. Sexual dysfunction with antihypertensive and antipsychotic agents. Clinical Pharmacy 1986, 5, 373–384.

    PubMed  CAS  Google Scholar 

  31. SMITH ER, MAURICE J, RICHARDSON R, WALTER T, DAVIDSON JM. Effects of four beta-adrenergic receptor antagonists on male sexual behaviour. Pharmacol Biochem Behav 1990, 36, 1713–1717.

    Google Scholar 

  32. SPARK RF, MELBY JC. Aldosteronism in hypertension. Ann Intern Med 1968, 69, 685–91.

    PubMed  CAS  Google Scholar 

  33. TURPIN G. Concours Médical 1991, 113(13), 1101.

    Google Scholar 

  34. WALLIS AA, BELL R, SUTHERLAND PW. Propranolol and Peyronie's disease. Lancet 1977, 1, 980.

    Article  Google Scholar 

  35. WASSERTHEIL-SMOLLER S, BLAUFOX MD, OBERMAN A, DAVIS BR, SWENCIONIS C et al. Effect of Antihypertensives on Sexual Function and Quality of Life: The TAIM Study. Ann Intern Med 1991, 114, 613–620.

    PubMed  CAS  Google Scholar 

  36. WEIN AJ, VAN ARSDALEN KN. Drug-induced Male Sexual Dysfunction. Urol Clin North Am 1988, 15(1), 23–31.

    PubMed  CAS  Google Scholar 

  37. WEISS RJ. Effects of antihypertensive agents on sexual function. Am Fam Phys 1991, 44(6), 2075–2082.

    CAS  Google Scholar 

  38. YLITALO P, PASTERNACK A. Priapism — side-effect of prazosin in patients with renal failure. Acta Med Scand 1983, 213, 319–20.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiologue 21, Avenue du Président Wilson, 75116, PARIS

    D. Gorin

Authors
  1. D. Gorin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gorin, D. Effet iatrogène des médicaments à visée cardiovasculaire sur la fonction sexuelle érectile de l'homme. Androl. 8, 391–404 (1998). https://doi.org/10.1007/BF03034576

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03034576

Mots clés

Key-words

Basic and Clinical Andrology

ISSN: 2051-4190